A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Leukemia

Topics

Biology

Biochemistry

Chemistry

Medicine

Immunology

Show all topics

DOI

10.1038/leu.2016.388

License

CC-BY

Other Formats

PDF